Last reviewed · How we verify

NCT06001944

Investigation of the Efficacy of Blood Flow Restricted Training in Lateral Elbow Tendinopathy

Status unknown NA Last updated 21 August 2023
What this trial tests

NA trial testing Blood flow restriction in Lateral Epicondylitis in 69 participants. Status unknown.

Timeline
11 April 2023
Primary endpoint
11 April 2024
11 April 2024

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment69
Start date11 April 2023
Primary completion11 April 2024
Estimated completion11 April 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 65, any sex, with Lateral Epicondylitis or Tennis Elbow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators believe that blood flow-restricted training can result in increased caste hypertrophy and strength without stressing the tendon in lateral elbow tendinopathy, and that changes in local metabolic activities can be effective in the process of tendon healing. The researchers' aim in the study is to investigate the effectiveness of blood flow restriction training in lateral elbow tendinopathy for 8 weeks, in addition to the 2 days a week multi-modal physiotherapy program, which will be applied by limiting blood flow by 40-50% occlusion recommended for the upper extremity using the patient's systolic pressure to the severity of 20-30% of 1 maximum repetition, 75 repetitions including 30-15-15-15 repetitions and 30 seconds rest period between sets, remaining attached to the recommended 10-15 minutes period for the top extremity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood flow restriction

Trials testing the same drug.

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06001944.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing